| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |